Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain Syndrome
Effects of Isokinetic Training Combined With Blood Flow Restriction in Patellofemoral Pain Syndrome
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized controlled trial aims to investigate the effects of isokinetic training combined with blood flow restriction (BFR) in individuals with patellofemoral pain syndrome (PFPS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2026
CompletedFirst Submitted
Initial submission to the registry
May 15, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
May 22, 2026
May 1, 2026
3 months
May 15, 2026
May 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Anterior Knee Pain Scale (AKPS)
The AKPS is a validated questionnaire used to assess pain and functional limitations associated with patellofemoral pain syndrome. Scores range from 0 to 100, with higher scores indicating better knee function and fewer symptoms.
From enrollment to the end of treatment at 4 weeks
Study Arms (3)
IT+BFR group
EXPERIMENTALIsokinetic Training Combined With Blood Flow Restriction
IT group
ACTIVE COMPARATORIsokinetic Training
ACE group
ACTIVE COMPARATORAerobic Cycling Exercise
Interventions
Participants in this group will receive supervised isokinetic muscle strength training targeting the knee musculature using an isokinetic dynamometer. Each session will last 30 minutes throughout the intervention period.
Participants in this group will receive isokinetic muscle strength training combined with blood flow restriction (BFR). BFR will be applied to the proximal thigh using a pneumatic cuff at an individualized pressure based on limb occlusion pressure. Isokinetic training will target the knee musculature using an isokinetic dynamometer under supervised conditions. Each session will last 30 minutes, with training performed multiple times per week throughout the intervention period.
Participants in this group will receive supervised aerobic cycling exercise using a stationary bicycle. Training will be performed at a moderate intensity for 30 minutes per session throughout the intervention period.
Eligibility Criteria
You may qualify if:
- Participants aged 18 to 40 years.
- Clinical diagnosis of patellofemoral pain syndrome (PFPS).
- Presence of anterior or retropatellar knee pain for at least 3 months.
- Pain provoked by at least two activities that increase patellofemoral joint load, including squatting, stair climbing, running, jumping, prolonged sitting, or kneeling.
- Average knee pain intensity of ≥3 on a 10-point visual analog scale (VAS) during aggravating activities.
- Ability to participate in exercise training and attend scheduled intervention sessions.
- Willingness to provide written informed consent.
You may not qualify if:
- History of knee surgery or significant trauma to the lower extremity within the previous 12 months.
- Clinical evidence of other knee disorders, including ligament injury, meniscal injury, patellar instability, osteoarthritis, or tendinopathy.
- Presence of neurological, cardiovascular, or systemic musculoskeletal disorders that may affect lower limb function or exercise participation.
- Current participation in other structured lower extremity rehabilitation or strength training programs.
- Contraindications to blood flow restriction training, including uncontrolled hypertension, vascular disease, thromboembolic disorders, or clotting abnormalities.
- Use of pain-relieving injections or surgical interventions for knee pain within the previous 6 months.
- Pregnancy.
- Inability to complete the assessment or intervention procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Mingzhou Rehabilitation Hospital
Nanjing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhang
Nanjing Mingzhou Rehabilitation Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Supervisor Technician
Study Record Dates
First Submitted
May 15, 2026
First Posted
May 22, 2026
Study Start
February 25, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share